Mirae Asset Global ETFs Holdings
TEVA icon

Mirae Asset Global ETFs Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
8,737
+1,023
+13% +$34.1K ﹤0.01% 2292
2026
Q1 		$232K Buy
7,714
+990
+15% +$31.9K ﹤0.01% 2284
2025
Q4 		$210K Buy
6,724
+414
+7% +$10.2K ﹤0.01% 2335
2025
Q3 		$127K Buy
6,310
+856
+16% +$15K ﹤0.01% 2559
2025
Q2 		$91.4K Buy
5,454
+430
+9% +$6.94K ﹤0.01% 2653
2025
Q1 		$77.2K Sell
5,024
-5,024
-50% -$89.7K ﹤0.01% 2736
2024
Q4 		$221K Buy
10,048
+5,526
+122% +$101K ﹤0.01% 2346
2024
Q3 		$81.5K Buy
+4,522
New +$79.1K ﹤0.01% 2790

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TEVA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Teva Pharmaceuticals (TEVA) stake by 13% in Q2 2026, buying an estimated $34.1K and bringing the position to 8,737 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Mirae Asset Global ETFs Holdings first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 8,737 shares of Teva Pharmaceuticals worth $296K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 1,023 Teva Pharmaceuticals shares in Q2 2026, an estimated $34.1K.
  • Teva Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2292 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.